MENLO PARK, Calif.--(BUSINESS WIRE)--Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the ...
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...
4don MSN
Immune sabotage: How a Vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...
A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback